IDNA | Carelon Clinical Guidelines and Pathways

Carelon Medical Benefits Management clinical appropriateness guidelines and cancer treatment pathways

Home 9 Tag: IDNA ( Page 6 )

ARCHIVED Solid and Hematologic Tumors 2021-05-10 to 2021-09-05

by dlamm | Sep 6, 2021 | Archived

ARCHIVED Hereditary Cancer Susceptibility 2021-03-08 to 2021-09-05

by dlamm | Sep 6, 2021 | Archived

ARCHIVED Solid and Hematologic Tumors 2021-02-08 to 2021-05-09

by dlamm | May 10, 2021 | Archived

ARCHIVED Whole Exome and Whole Genome Sequencing 2020-09-01 to 2021-03-07

by dlamm | Mar 8, 2021 | Archived

ARCHIVED Pharmacogenomic Testing and Genetic Testing for Thrombotic Disorders 2020-09-01 to 2021-03-07

by dlamm | Mar 8, 2021 | Archived

« Older Entries

Next Entries »